trans,trans-4'-Pentyl-4-(3,4,5-trifluorophenyl)bicyclohexyl>98.0%(GC)5g

(4-Methoxy-3-methylpyridin-2-yl)methanol, 95.0%, 1g

THIENO[3,2-B]PYRIDINE-7-CARBOXYLIC ACID, 95.0%, 250mg

(R)-2-((6R,8R)-7,7-Dimethyl-5,6,7,8-tetrahydro-6,8-methanoquinolin-2-yl)-4-phenyl-4,5-dihydrooxazole, 98%, 250mg

METHYL 2-AMINO-4-HYDROXY-5-METHOXYBENZOATE, 95.0%, 1g

BENZYL (6-CHLORO-5-FLUOROPYRIDIN-3-YL)CARBAMATE, 90.0%, 1g

Methyl 3-methyl-4-oxotetrahydro-2H-pyran-3-carboxylate, 95.0%, 10g

N,N-dimethyl-4-{[(prop-2-en-1-yl)amino]methyl}aniline, 95.0%, 1g

tert-Butyl thiazol-5-ylcarbamate, 95.0%, 5g

(Z)-N',2-Dihydroxybenzimidamide, 98%, 1g

(S,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate, 96%, 1g

1-Butanol, min. 99.5%, for synthesis, 250 ml, glass packaging

(2S)-1-(azepan-1-yl)propan-2-amine dihydrochloride, 95.0%, 250mg